Dr. Paddy Barrett

OCTOBER 11, 2024

Dementia is a leading cause of death and a major concern for most people as they age. Optimal metabolic health is linked to reduced rates of dementia, but the question again is whether the use of medications such as Ozempic might also delay the onset of dementia. 2024 Jun 21. Obstructive Sleep Apnea (OSA). N Engl J Med.

Obesity 85

Obesity Cancer Dementia Coronary Artery Disease 85

DAIC

SEPTEMBER 11, 2024

tim.hodson Wed, 09/11/2024 - 15:40 Sept. 11, 2024 — In the first national estimate in two decades, researchers at the University of California-San Francisco (UCSF) report that 10.5 million Americans have atrial fibrillation. million U.S. adults, according to new estimates from University of California-San Francisco. million U.S.

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

Dr. Paddy Barrett

SEPTEMBER 13, 2024

Everyone sits somewhere on the scale of insulin sensitivity from very insulin sensitive to very insulin resistant at the point of type 2 diabetes. Understanding where you sit on this continuum is a key part of defining your future risk of heart disease but also dementia, and many cancers. BMC Public Health 24 , 574 (2024).

Risk Factors 105

Risk Factors Heart Disease Dementia Diabetes 105

Physiologically Speaking

AUGUST 23, 2024

Cognitive decline, including Alzheimer’s disease and dementia, is one of the largest causes of death and disability around the world (and all data indicate the rates are rising). 2024 Aug 27;121(35):e2402813121. Epub 2024 Aug 19. When our mind fails, our body follows. The usual questions and caveats apply here. 2402813121.

Physiology 122

Physiology Exercise Laboratory Dementia 122

DAIC

SEPTEMBER 11, 2024

tim.hodson Wed, 09/11/2024 - 15:40 Sept. A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. million Americans have atrial fibrillation. million U.S. million U.S. The study appears Sept.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP273-AWP273, February 1, 2024. Those with high mRS were more likely to have high school-only education or a diagnosis of dementia on admission compared to those with low mRS. Those with high school-only education were 2.94 Similarly, those with a diagnosis of dementia on admission, were 6.22

Hemorrhage 40

Hemorrhage Dementia Outcomes Education 40

Cardiometabolic Health Congress

APRIL 12, 2024

New Addition to the Clinical Toolkit On March 22, 2024, the US FDA approved broad new label expansions for Esperion’s NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets. Esperion expects the European Medicines Agency to give a final decision in the second quarter of 2024.

Myocardial Infarction 64

Myocardial Infarction Cardiovascular Disease Heart attacks Heart Attack 64

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP255-AWP255, February 1, 2024. Asymptomatic intracranial large artery stenosis (ILAS) has been associated with higher risk of stroke and dementia. The mean concentration of NFL was 0.19±0.10 pg/mL with a mean intra-assay coefficient of variation equal to 8.2%.

Stenosis 40

Stenosis Dementia Hypertension Biomarkers 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP239-AWP239, February 1, 2024. Evidence shows that in diabetic men, intima-media thickness is significantly higher in those with ApoE4 than those with ApoE3. Whether these interactions influence the risk of stroke and dementia should be further investigated. 0.20, p=0.01.Conclusion:ApoE4

Stenosis 40

Stenosis Risk Factors Hypertension Dementia 40

Stroke Journal

JANUARY 30, 2025

While it is generally held that faster reperfusion is associated with better patient outcomes, the magnitude of benefit in achieving the goal of DTD </= 90 has not been systematically studied.Methods:This is a retrospective analysis of acute ischemic stroke (AIS) patients from a multi-state stroke registry between January 2016 through March (..)

Outcomes 40

Outcomes Atrial Fibrillation Dementia Stroke 40

Physiologically Speaking

OCTOBER 4, 2024

Specifically, the weekend warriors had a 26% lower dementia risk, a 21% lower stroke risk, a 45% lower Parkinson’s disease risk, a 40% lower depression risk, and a 37% lower anxiety risk compared to inactive participants (after adjusting for age and sex). Nat Aging (2024). Just use the coupon code BRADY30 at checkout.

Exercise 105

Exercise Physiology Dementia Obesity 105

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4140001-A4140001, November 12, 2024. Background:Aged heart failure (HF) patients without dementia have a risk of cognitive impairment (CI) that attenuates the effect of treatment for HF. We excluded patients with dementia using mini-mental state examination. 0.63, P=0.01).

Dementia 40

Dementia Heart Failure Blood Pressure Atrial Fibrillation 40

Dr. Paddy Barrett

FEBRUARY 28, 2025

Lower levels of muscle mass are strongly linked to a shorter life and higher rates of major chronic diseases such as diabetes 2. Cognitive Performance & Dementia. There is also mechanistic data to support its role in preventing dementia, but for now, this is more speculative 10. 2024 Dec 3;15:1496544. Sports Med.

Blood Pressure 84

Blood Pressure Dementia Quality of Life Webinar 84

Dr. Smith's ECG Blog

FEBRUARY 26, 2025

Written by Magnus Nossen, edits by Smith The patient in today's case is an 85-year-old male with a history of COPD and dementia. Due to very severe dementia, it was impossible to obtain a detailed history. He presented to the emergency department for evaluation. Lets us consider two different clinical presentations. 4] Wang, S.,

Chest Pain 88

Chest Pain Pericarditis Myocardial Infarction Dementia 88

Dr. Malcolm Kendrick

OCTOBER 30, 2024

Burning torches will be provided to all those who turn up. 1: [link] 2: [link] 3: KINGS BENCH DIVISION IN THE HIGH COURT Claim Nos. plus drug supply Bayer: £1.8M plus drug supply ASCEND PLUS (2021 – ongoing) Novo Nordisk A/S: £39.4M Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M

Cholesterol 145

Cholesterol Article Research Diet 145